<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02460523</url>
  </required_header>
  <id_info>
    <org_study_id>borderline CBDS</org_study_id>
    <nct_id>NCT02460523</nct_id>
  </id_info>
  <brief_title>Management of Borderline Common Bile Duct Stone</brief_title>
  <acronym>CBDS</acronym>
  <official_title>Management and Outcome of Borderline Common Bile Duct With Stone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the best line of treatment of borderline CBD stones associated with gallbladder&#xD;
      stones whether by conservative treatment or endoscopic stone extraction as regard complete&#xD;
      clearance rate of the CBD stones followed by laparoscopic cholecystectomy. The secondary&#xD;
      outcomes are overall complications related to each approach, technical difficulties and&#xD;
      conversion rate during laparoscopic cholecystectomy and cost benefit relationship of each&#xD;
      line of treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Enrolled patients in the study will be randomized to either conservative treatment or ERCP&#xD;
      and stone extraction. The randomization process will be done using closed envelop method and&#xD;
      will be withdrawn by a nurse in the outpatient clinic.&#xD;
&#xD;
        1. Patients in conservative treatment group will receive medical treatment in the form of&#xD;
           antibiotics, analgesics and antispasmodics for 3 days. These patients will be followed&#xD;
           up for improvement on the ground of clinical symptoms and serum bilirubin level and&#xD;
           abdominal US for CBD stones.&#xD;
&#xD;
             1. Improvement: If the stone spontaneously passes to the duodenum and CBD is clear&#xD;
                completely from the stones proved by US, the patient will undergo laparoscopic&#xD;
                cholecystectomy (LC) within 3 days.&#xD;
&#xD;
             2. No improvement: the patient will undergo ERCP and then LC.&#xD;
&#xD;
        2. Patients in ERCP group will undergo ERCP and wide papillotomy and stone extraction&#xD;
           directly then laparoscopic cholecystectomy (LC) within 3 days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>complete clearance rate of the CBD stones</measure>
    <time_frame>30 DAYS</time_frame>
    <description>complete clearance rate of the CBD stones</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>overall complications</measure>
    <time_frame>30 DAYS</time_frame>
    <description>pancreatitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>conversion rate during laparoscopic cholecystectomy</measure>
    <time_frame>1 day</time_frame>
    <description>conversion rate during laparoscopic cholecystectomy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Common Bile Duct Stone</condition>
  <arm_group>
    <arm_group_label>conservative</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1- Patients in conservative treatment group will receive medical treatment in the form of antibiotics (3rd generation cephalosporine), analgesics (NSAID eg Ibuprofen ) and antispasmodics for 3 days. These patients will be followed up for improvement on the ground of clinical symptoms and serum bilirubin level and abdominal US for CBD stones.&#xD;
Improvement: If the stone spontaneously passes to the duodenum and CBD is clear completely from the stones proved by US, the patient will undergo laparoscopic cholecystectomy (LC) within 3 days.&#xD;
No improvement: the patient will undergo ERCP and then LC.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ERCP (endoscopic)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2- Patients in ERCP group will undergo ERCP and wide papillotomy and stone extraction directly then laparoscopic cholecystectomy (LC) within 3 days.cholecystectomy (LC) within 3 days.&#xD;
b- No improvement: the patient will undergo ERCP and then LC.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conservative</intervention_name>
    <description>1- Patients in conservative treatment group will receive medical treatment in the form of antibiotics (3rd generation cephalosporine), analgesics (NSAID eg Ibuprofen) and antispasmodics for 3 days. These patients will be followed up for improvement on the ground of clinical symptoms and serum bilirubin level and abdominal US for CBD stones.</description>
    <arm_group_label>conservative</arm_group_label>
    <other_name>G 1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERCP</intervention_name>
    <description>2- Patients in ERCP group will undergo ERCP and wide papillotomy and stone extraction directly then laparoscopic cholecystectomy (LC) within 3 days.</description>
    <arm_group_label>ERCP (endoscopic)</arm_group_label>
    <other_name>G 2</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          1. CBD diameter less than 10mm.&#xD;
&#xD;
          2. Single or 2 stones in number.&#xD;
&#xD;
          3. Size of stone 5mm or less.&#xD;
&#xD;
          4. Serum bilirubin level less than 10 mg/dl .&#xD;
&#xD;
          5. SGPT, SGOT less than 300.&#xD;
&#xD;
          6. Associated gallbladder stones&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous cholecystectomy.&#xD;
&#xD;
          2. History of acute cholecystitis, pancreatitis, or cholangitis.&#xD;
&#xD;
          3. Previous history of endoscopic sphincterotomy.&#xD;
&#xD;
          4. Unfit patients for cholecystectomy.&#xD;
&#xD;
          5. No gallbladder stones.&#xD;
&#xD;
          6. Patients with altered GIT anatomy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ayman El Nakeeb, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <link>
    <url>http://www.mans.edu.eg/</url>
    <description>mansoura university</description>
  </link>
  <results_reference>
    <citation>Hungness ES, Soper NJ. Management of common bile duct stones. J Gastrointest Surg. 2006 Apr;10(4):612-9. Review.</citation>
    <PMID>16627230</PMID>
  </results_reference>
  <results_reference>
    <citation>Freitas ML, Bell RL, Duffy AJ. Choledocholithiasis: evolving standards for diagnosis and management. World J Gastroenterol. 2006 May 28;12(20):3162-7. Review.</citation>
    <PMID>16718834</PMID>
  </results_reference>
  <results_reference>
    <citation>Samardzic J, Latic F, Kraljik D, Pitlovic V, Mrkovic H, Miskic D, Latic A, Delibegovic S. Treatment of common bile duct stones--is the role of ERCP changed in era of minimally invasive surgery? Med Arh. 2010;64(3):187-8.</citation>
    <PMID>20645517</PMID>
  </results_reference>
  <verification_date>April 2012</verification_date>
  <study_first_submitted>May 22, 2015</study_first_submitted>
  <study_first_submitted_qc>May 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2015</study_first_posted>
  <last_update_submitted>July 20, 2015</last_update_submitted>
  <last_update_submitted_qc>July 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Ayman El Nakeeb</investigator_full_name>
    <investigator_title>Gastroenterology surgical center, mansoura university</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

